EUVIMEDEUVIMED entdecken
Crossref

Discovery of an Ultrasound-Responsive Arylurea-Dihydrotetrazine Architecture for Ultrasound-Programmed Bioorthogonal Chemistry

Shuanglong Chen, Jiaxin Chang, Mingxin Cheng, Chao Ban, Weiwei Guo iD, Yueqin Zheng iD

Journal of the American Chemical Society · 2026

DOI: 10.1021/jacs.6c13439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Shuanglong Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Center of Drug Discovery, China Pharmaceutical University, Nanjing, Jiangsu211198, China. Hauptthemen laut MEDLINE: Urea, Ultrasonic Waves, Antineoplastic Agents, Tetrazoles. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Lingang Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ultrasound-responsive chemical scaffolds capable of operating under clinically relevant conditions remain rare, limiting the development of programmable ultrasound-controlled molecular systems. Here, we report the discovery of a stable yet ultrasound-responsive arylurea-dihydrotetrazine (ArU-DHTz) scaffold that undergoes efficient activation under 1 MHz therapeutic ultrasound without requiring exogenous sonosensitizers. Structure–responsiveness studies revealed that activation arises from a unique combination of a monosubstituted arylurea motif and an appropriately tuned DHTz core, while mechanistic investigations identified cavitation-derived hydroxyl radicals as the primary activating species. Ultrasound activation simultaneously triggers cargo release and tetrazine generation, representing, to our knowledge, the first example of ultrasound-triggered tetrazine formation. Leveraging tetrazine as a chemical relay, we developed a “Release–Relay–Click” strategy that converts a single ultrasound input into dual molecular outputs: therapeutic payload release and downstream click-to-release activation. Representative prodrug D6 showed ultrasound-dependent activation, translating into antitumor efficacy in vitro and in vivo, together with fluorescence self-reporting through tetrazine-mediated bioorthogonal chemistry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UreaUltrasonic WavesAntineoplastic AgentsTetrazolesHumansAnimalsMolecular StructureClick Chemistry

Substanzen

UreaAntineoplastic AgentsTetrazoles

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Center of Drug Discovery, China Pharmaceutical University, Nanjing, Jiangsu211198, China.

ORCID-Profile: Weiwei Guo, Yueqin Zheng

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Lingang Laboratory

Zitieren

APA

Chen, S., Chang, J., Cheng, M., Ban, C., Guo, W., & Zheng, Y. (2026). Discovery of an Ultrasound-Responsive Arylurea-Dihydrotetrazine Architecture for Ultrasound-Programmed Bioorthogonal Chemistry. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c13439

Vancouver

Chen S, Chang J, Cheng M, Ban C, Guo W, Zheng Y. Discovery of an Ultrasound-Responsive Arylurea-Dihydrotetrazine Architecture for Ultrasound-Programmed Bioorthogonal Chemistry. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c13439

BibTeX
@article{Chen2026,
  author = {Chen, Shuanglong and Chang, Jiaxin and Cheng, Mingxin and Ban, Chao and Guo, Weiwei and Zheng, Yueqin},
  title = {Discovery of an Ultrasound-Responsive Arylurea-Dihydrotetrazine Architecture for Ultrasound-Programmed Bioorthogonal Chemistry},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  doi = {10.1021/jacs.6c13439}
}
Kostenlos starten →